Clinical Trials Directory

Trials / Completed

CompletedNCT00271232

InSync III Marquis Model 7279 Cardioverter Defibrillator Cardiac Resynchronization System

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
238 (planned)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

People who have a dangerously fast heart beat, or whose heart is at risk of stopping beating, may be in need of an electronic device called an implantable cardioverter defibrillator (ICD). An ICD is implanted surgically just under the skin in the upper chest area and it sends a strong electrical impulse, or shock, to the heart to return it to a normal rhythm. If the heart is beating too slowly or at an abnormal rhythm, an ICD can also pace the heart to return the heart to its normal rhythm. The InSync III Marquis device can change the timing of when the left and right ventricles of the heart are paced to beat. This is called "V to V timing". V to V timing may further improve the pumping function of the heart. The purpose of this study is to determine whether or not this V to V timing feature of the InSync III Marquis system is safe and effective.

Conditions

Interventions

TypeNameDescription
DEVICECardiac resynchronization therapy

Timeline

Start date
2003-03-01
Completion
2005-04-01
First posted
2005-12-30
Last updated
2007-12-21

Locations

34 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00271232. Inclusion in this directory is not an endorsement.